Inhibition of Peroxidase Activity of Cytochrome c: De Novo Compound Discovery and Validation

Ahmet Bakan1, Alexandr A Kapralov1, Hulya Bayir1

  • 1Department of Computational and Systems Biology, School of Medicine (A.B., F.H., I.B.), and Department of Environmental and Occupational Health (A.A.K., H.B., V.E.K.), University of Pittsburgh, Pittsburgh, Pennsylvania.

Insights

Researchers identified drugs that inhibit cytochrome c peroxidase activity, a key step in apoptosis. This finding offers a new strategy to control programmed cell death by targeting mitochondrial permeability.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Pharmacology

Background:

  • Cytochrome c (cyt c) release from mitochondria triggers apoptosis.
  • Mitochondrial permeability pore opening, enhanced by cyt c's peroxidase activity, is crucial for apoptosis.
  • Inhibiting cyt c's peroxidase activity, particularly its heme group access, can control apoptosis.

Purpose of the Study:

  • To identify compounds that inhibit the peroxidase activity of cytochrome c.
  • To explore therapeutic strategies for controlling apoptosis by targeting cyt c.

Main Methods:

  • Druggability simulations
  • Pharmacophore modeling
  • Virtual screening
  • In vitro fluorescence measurements

Main Results:

  • Identified three repurposable drugs that inhibit cyt c peroxidase activity.
  • Identified seven novel compounds that inhibit cyt c peroxidase activity.
  • Validated the compounds' efficacy in inhibiting peroxidase activity.

Conclusions:

  • Blocking access to the heme group of cyt c is an effective strategy to reduce its peroxidase activity.
  • The identified drugs and compounds show potential for therapeutic intervention in apoptosis-related conditions.

Related Concept Videos

The Electron Transport Chain01:30

The Electron Transport Chain

The electron transport chain or oxidative phosphorylation is an exothermic process in which free energy released during electron transfer reactions is coupled to ATP synthesis. This process is a significant source of energy in aerobic cells, and therefore inhibitors of the electron transport chain can be detrimental to the cell's metabolic processes.
Inhibitors of the electron transport chain
Rotenone, a widely used pesticide, prevents electron transfer from Fe-S cluster to ubiquinone or Q...
21.6K
Enzyme Inhibition01:30

Enzyme Inhibition

Inhibitors are molecules that reduce enzyme activity by binding to the enzyme. In a normally functioning cell, enzymes are regulated by a variety of inhibitors. Drugs and other toxins can also inhibit enzymes. Some inhibitors bind to the enzyme’s active site, while others inhibit enzymatic activity by binding to other sites on the protein structure.
95.2K
Peroxisomes01:24

Peroxisomes

Peroxisomes are specialized organelles present in fungi, plant, and animal cells. It can vary in number, size, morphology, and activity depending on the type of tissue and the nutritional state of the cell. For example, cells with active lipid metabolism, such as adipocytes, neurons, and hepatocytes, have more peroxisomes than other cells in the body. Besides their primary role in breaking down complex organic molecules, peroxisomes can also synthesize specific macromolecules and participate in...
22.2K
Oxidation of Phenols to Quinones01:17

Oxidation of Phenols to Quinones

In the presence of oxidizing agents, phenols are oxidized to quinones. Quinones can be easily reduced back to phenols using mild reducing agents. The electron-donating hydroxyl group enhances the reactivity of the aromatic ring, enabling oxidation of the ring even in the absence of an α hydrogen.
o-hydroxy phenols are oxidized to o-quinones and p-hydroxy phenols to p-quinones. Such redox reactions involve the transfer of two electrons and two protons. The reversible redox...
5.3K
Inhibition of CDK Activity02:34

Inhibition of CDK Activity

5.7K
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
6.2K